There was no significant intergroup difference in the mRNA expression level of TRPC3 on days 1 and 3, whereas the mRNA expression of TRPC3 in the BPD group was lower than that in the control group from day 5 onward (p < 0.01). This evidence concerns the gene TRPC3 and bronchopulmonary dysplasia.